Intervention NHs (n = 59) | Control NHs (n = 64) | ||||||
---|---|---|---|---|---|---|---|
Medication use | Study beginning | End of follow-up | p-vvalue** | Study beginning | End of follow-up | p-vvalue** | p-vvalue*** |
Total number of regular medications (n) | 416 | 389 | 492 | 369 | |||
Number of all medications per participant (mean ± SE) | 8.15 ± 0.76 | 7.76 ± 0.73 | 0.28 | 10.73 ± 1.04 | 9.17 ± 0.91 | 0.0001 | 0.0806 |
Number of regular medications per participant (mean ± SE) | 7.06 ± 0.45 | 6.60 ± 0.43 | 0.2126 | 7.69 ± 0.45 | 5.90 ± 0.40 | < 0.0001 | 0.0092 |
Total number of regular “generally appropriate” medications (n) | 140 | 127 | 156 | 121 | |||
Total number of regular “sometimes appropriate” medications (n) | 284 | 265 | 313 | 241 | |||
Total number of regular “exceptionally appropriate” medications (n) | 13 | 13 | 24 | 19 | |||
Proportion of participants using regular “generally appropriate” medications (%) | 86 | 81 | 0.4438 | 88 | 76 | 0.4583 | 0.9464 |
Proportion of participants using regular “sometimes appropriate” medications (%) | 98 | 100 | 0.0917 | 98 | 98 | 0.1201 | 0.2770 |
Proportion of participants using regular “exceptionally appropriate” medications (%) | 19 | 17 | 0.4331 | 28 | 21 | 0.0069 | 0.2168 |
Total number of residents with regular antipsychotics (n)a | 38 | 34 | 25 | 19 | |||
Number of regular antipsychotics per participant (mean ± SE)a | 0.64 ± 0.09 | 0.58 ± 0.09 | 0.2141 | 0.39 ± 0.07 | 0.30 ± 0.06 | 0.0199 | 0.2687 |
CMAI (mean ± SE) | 38.8 ± 1.4 | 35.6 ± 1.5 | 0.0002 | 36.0 ± 1.5 | 35.5 ± 1.5 | 0.5267 | 0.0262 |
PACSLAC-F short version (mean ± SE, range) | 4.91 ± 0.41 | 4.29 ± 0.44 | 0.0577 | 4.06 ± 0.40 | 4.34 ± 0.44 | 0.3783 | 0.0487 |